Allen Mooney & Barnes Investment Advisors LLC Gilead Sciences, Inc. Transaction History

Allen Mooney & Barnes Investment Advisors LLC

$559 Billion
Q2 2024

A detailed history of Allen Mooney & Barnes Investment Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Allen Mooney & Barnes Investment Advisors LLC holds 20,326 shares of GILD stock, worth $1.6 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

20,326

Previous 20,652 1.58%

Holding current value

$1.6 Million

Previous $1.42 Billion 1.64%

% of portfolio

0.25%

Previous 0.27%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$63.15 - $72.88 $20,586 - $23,758	-326 Reduced 1.58%	20,326 $1.39 Billion
Q1 2024 Apr 12, 2024	SELL	$71.58 - $87.29 $27,629 - $33,693	-386 Reduced 1.83%	20,652 $1.42 Billion
Q4 2023 Jan 22, 2024	BUY	$73.27 - $83.09 $15,533 - $17,615	212 Added 1.02%	21,038 $1.7 Billion
Q3 2023 Nov 21, 2023	BUY	$73.94 - $80.67 $1.54 Million - $1.68 Million	20,826 New	20,826 $1.56 Billion
Q2 2023 May 23, 2024	BUY	$76.01 - $86.7 $20,902 - $23,842	275 Added 1.33%	20,897 $1.61 Billion
Q1 2023 May 23, 2024	SELL	$77.31 - $88.08 $75,841 - $86,406	-981 Reduced 4.54%	20,622 $1.71 Billion
Q4 2022 May 23, 2024	BUY	$62.32 - $89.47 $59,266 - $85,085	951 Added 4.6%	21,603 $1.85 Billion
Q3 2022 May 23, 2024	SELL	$59.54 - $68.01 $37,450 - $42,778	-629 Reduced 2.83%	21,632 $1.33 Billion
Q2 2022 May 23, 2024	SELL	$57.72 - $65.01 $48,773 - $54,933	-845 Reduced 3.66%	22,261 $1.38 Billion
Q1 2022 May 23, 2024	BUY	$57.92 - $72.58 $142,135 - $178,111	2,454 Added 11.88%	23,106 $1.37 Billion

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $98.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Mooney & Barnes Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Mooney & Barnes Investment Advisors LLC with notifications on news.

Account

Allen Mooney & Barnes Investment Advisors LLC Gilead Sciences, Inc. Transaction History